Company / Free Cash Flow
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$113.9M
FY2025
5-year range
-$280.0M / -$113.9M
FY2021-FY2025
Trend
+46.3%
vs FY2024
Sector context
#143 of 151
Health Care
What the data says
Among 151 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 5% for free cash flow. Free Cash Flow has increased for 3 consecutive years, from -$280M in FY2022 to -$114M in FY2025.
Based on SEC 10-K filings.
-$114M in FY2025.
Improved from -$268M to -$114M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 151This company -$113.9M Sector average $779.8M
▼
-114.6% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 46.3% year-over-year.
- Ranks #143 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$113.9M | +46.3% |
| FY2024 | -$212.2M | +20.8% |
| FY2023 | -$268.0M | +4.3% |
| FY2022 | -$280.0M | -139.1% |
| FY2021 | -$117.1M | -734.3% |
| FY2020 | $18.5M | +122.8% |
| FY2019 | -$81.1M | -18.8% |
| FY2018 | -$68.3M | +12.4% |
| FY2017 | -$78.0M | -2.4% |
| FY2016 | -$76.1M | -147.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026